Not known Factual Statements About cgmp compliance
No. 21 CFR 211.113(a) calls for suitable written procedures being recognized and followed during manufacturing to stop objectionable microorganisms in drug products not required to be sterile. Moreover, the second paragraph of USP Standard Chapter Antimicrobial Usefulness Screening reads: Antimicrobial preservatives shouldn't be employed a